Cambridge, United Kingdom

Lorna McLeod Williamson

This inventor holds 1 USPTO granted patent. Top assignee: University of Cambridge. Active years: 2009.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lorna McLeod Williamson: Innovator in Binding Molecules

Introduction

Lorna McLeod Williamson is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules derived from immunoglobulins. Her innovative work focuses on creating molecules that can bind target substances without triggering adverse immune responses.

Latest Patents

Lorna McLeod Williamson holds a patent for "Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis." This patent discloses recombinant polypeptides that contain a binding domain capable of binding a target molecule and an effector domain with an amino acid sequence substantially homologous to a constant domain of a human immunoglobulin heavy chain. The binding molecules are characterized by their ability to bind target molecules without causing significant complement-dependent lysis or cell-mediated destruction. The patent also discusses the modification of specific regions to render the molecule null allotypic, along with the disclosure of nucleic acids, host cells, production processes, and pharmaceutical preparations.

Career Highlights

Lorna McLeod Williamson is affiliated with the University of Cambridge, where she continues her research and development in the field of immunology and biotechnology. Her work has garnered attention for its potential applications in therapeutic settings, particularly in the design of safer and more effective binding molecules.

Collaborations

Lorna has collaborated with notable colleagues, including Kathryn Lesley Armour and Michael Ronald Clark, contributing to advancements in their shared field of research.

Conclusion

Lorna McLeod Williamson's innovative work in binding molecules represents a significant advancement in biotechnology. Her contributions have the potential to impact various therapeutic applications, showcasing the importance of her research in the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…